In The News
Johnson & Johnson hit with class action over ‘carcinogenic’ baby powder
Reporter settles sex discrimination case against Nine
Monsanto’s condition on Roundup class action discontinuance unfair, judge says
‘I have taken it all’: Lawyer struck off roll after gutting trust account
Pawn shop facing class action loses bid for pro bono lawyers
Baker McKenzie, others win $3.5M security in Armour takeover case
Novartis appeals IP win for Pharmacor over blood pressure drug
Pinsent Masons nabs lawyers from DLA Piper, Norton Rose
Sportsbet faces class action over ‘fast code’ betting service
Hytera launches High Court challenge in IP dispute with Motorola
Please login to bookmark Close

Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au